James Patrick Kelly is EVP, CFO and Treasurer of NOVAVAX INC. Currently has a direct ownership of 69,251 shares of NVAX, which is worth approximately $484,757. The most recent transaction as insider was on Mar 07, 2025, when has been sold 5,904 shares (Common Stock) at a price of $8.34 per share, resulting in proceeds of $49,239. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.3K
112.41% 3M change
421.27% 12M change
Total Value Held $484,757

James Patrick Kelly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2025
SELL
Payment of exercise price or tax liability
$49,239 $8.34 p/Share
5,904 Reduced 7.86%
69,251 Common Stock
Mar 07 2025
BUY
Exercise of conversion of derivative security
-
12,223 Added 13.99%
75,155 Common Stock
Mar 01 2025
SELL
Payment of exercise price or tax liability
$236,047 $8.33 p/Share
28,337 Reduced 31.05%
62,932 Common Stock
Mar 01 2025
BUY
Exercise of conversion of derivative security
-
58,667 Added 39.13%
91,269 Common Stock
Dec 31 2024
SELL
Payment of exercise price or tax liability
$135,924 $8.04 p/Share
16,906 Reduced 34.15%
32,602 Common Stock
Dec 31 2024
BUY
Exercise of conversion of derivative security
-
35,000 Added 41.42%
49,508 Common Stock
Aug 16 2024
SELL
Payment of exercise price or tax liability
$15,850 $12.96 p/Share
1,223 Reduced 7.81%
14,429 Common Stock
Aug 16 2024
BUY
Exercise of conversion of derivative security
$30,676 $12.96 p/Share
2,367 Added 13.14%
15,652 Common Stock
Mar 10 2024
SELL
Payment of exercise price or tax liability
$12,131 $5.45 p/Share
2,226 Reduced 14.35%
13,285 Common Stock
Mar 10 2024
BUY
Exercise of conversion of derivative security
-
4,608 Added 22.9%
15,511 Common Stock
Mar 07 2024
SELL
Payment of exercise price or tax liability
$33,127 $5.61 p/Share
5,905 Reduced 35.13%
10,903 Common Stock
Mar 07 2024
BUY
Exercise of conversion of derivative security
-
12,224 Added 42.11%
16,808 Common Stock
Aug 16 2023
SELL
Payment of exercise price or tax liability
$8,149 $7.13 p/Share
1,143 Reduced 19.96%
4,584 Common Stock
Aug 16 2023
BUY
Exercise of conversion of derivative security
-
2,366 Added 29.24%
5,727 Common Stock
Mar 10 2023
SELL
Payment of exercise price or tax liability
$16,110 $6.52 p/Share
2,471 Reduced 42.37%
3,361 Common Stock
Mar 10 2023
BUY
Exercise of conversion of derivative security
$30,050 $6.52 p/Share
4,609 Added 44.14%
5,832 Common Stock
Aug 16 2022
SELL
Payment of exercise price or tax liability
$49,055 $42.88 p/Share
1,144 Reduced 48.33%
1,223 Common Stock
Aug 16 2022
BUY
Exercise of conversion of derivative security
-
2,367 Added 50.0%
2,367 Common Stock

Also insider at

SUPN
SUPERNUS PHARMACEUTICALS, INC. Healthcare
JPK

James Patrick Kelly

EVP, CFO and Treasurer
Gaithersburg, MD

Track Institutional and Insider Activities on NVAX

Follow NOVAVAX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVAX shares.

Notify only if

Insider Trading

Get notified when an Novavax Inc insider buys or sells NVAX shares.

Notify only if

News

Receive news related to NOVAVAX INC

Track Activities on NVAX